from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1476/-

LFCtreatmentdescriptionclass of inhibitor

-1.188

Amikacinug/mL Amikacintranslation

-0.153

Cap5-10ug/mL Capreomycintranslation

-0.120

Rox10-50 ug/mL Roxithromycintranslation

-0.309

SM2-5 ug/mL Streptomycintranslation

-1.493

Tet5-10 ug/mL Tetracyclinetranslation

-0.181

Rif0.2-5ug/mL Rifampicintranscription

-0.561

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.621

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.252

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.306

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.886

Clofazimine10-13 ug/mL Clofaziminerespiration

0.242

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.012

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.168

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.012

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.146

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.939

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.557

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.105

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.279

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.706

KCN5-20 ug/mL Potassium cyaniderespiration

0.300

NaN30.2-2 mM Sodium aziderespiration

-0.488

Nigericin50 uM Nigericinrespiration

-0.536

TRC10-150 ug/mL Triclosanrespiration

-0.182

TRZ10-25 ug/mL Thioridazinerespiration

-1.186

Valinomycin0.5-10 uM Valinomycinrespiration

1.607

ZnSO42 mM ZnSO4respiration

0.826

menadione6-10 ug/mL Menadionerespiration

-0.573

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.142

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.072

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.321

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.405

NRP_1Non-replicating persistence stage 1dosRassociated

-0.151

Amp0.2mg/mL AmpicillincellWall

0.496

Cephalexin20-100 ug/mL CephalexincellWall

0.013

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.247

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.568

EMB10-20 ug/mL EthambutolcellWall

0.120

Eta12-40 ug/mL EthionamidecellWall

-0.229

INH0.2-0.4 ug/mL IsoniazidcellWall

0.355

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.205

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.391

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.528

BZA0.12 mg/mL BenzamidearomaticAmides

0.461

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.477

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.285

H2O24 mM hydrogen peroxideDNAdamaging

1.140

Levo10 ug/mL LevofloxacinDNAdamaging

1.153

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.302

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.709

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.037

UVUV-irradiationDNAdamaging

-0.375

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.228

Antimycin12.5-50 ug/mL Antimycin A?

0.249

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.028

PA_110-50 ug/mL Antitubercular compound PA-1?

0.700

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.267

PA8240.2-2 ug/mL PA-824?

-1.297

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.170

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.412

Verapamil50 uM Verapamil?

0.441

mercaptoethanol2 mM 2-Mercaptoethanol?

0.199

methoxatin10-20 ug/mL Methoxatin?